Impact of bone metastases (BM) and bisphosphonate use in patients with metastatic renal cell carcinoma (mRCC) treated with targeted therapy: Results from a pooled clinical trials database

被引：0
|
作者：
Mckay, R. R. [1 ]
Lin, X. [2 ]
Perkins, J. J. [2 ]
Heng, D. Y. C. [3 ]
Simantov, R. [2 ]
Choueiri, T. K. [1 ]
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Pfizer Oncol, New York, NY USA
[3] Tom Baker Canc Clin, Calgary, AB, Canada
来源：
BJU INTERNATIONAL | 2013年 / 112卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
16
引用
收藏
页码：10 / 11
页数：2
相关论文
共 50 条
  • [21] Outcomes of Patients With Metastatic Renal Cell Carcinoma and Bone Metastases in the Targeted Therapy Era
    Kalra, Sarathi
    Verma, Jonathan
    Atkinson, Bradley J.
    Matin, Surena F.
    Wood, Christopher G.
    Karam, Jose A.
    Lin, Sue-Hwa
    Satcher, Robert L.
    Tamboli, Pheroze
    Sircar, Kanishka
    Rao, Priya
    Corn, Paul G.
    Tannir, Nizar M.
    Jonasch, Eric
    CLINICAL GENITOURINARY CANCER, 2017, 15 (03) : 363 - 370
  • [22] Multicenter retrospective analysis of patients with metastatic renal cell carcinoma (mRCC) and bone metastases treated with ipilimumab and nivolumab
    Desai, Kunal
    Brown, Landon Carter
    Wei, Wei
    Allman, Kimberly D.
    Martin, Allison
    Wood, Laura S.
    Gupta, Shilpa
    Gilligan, Timothy D.
    Garcia, Jorge A.
    Kao, Chester
    Kinsey, Emily Noelle
    Healy, Patrick
    Kephart, Julie
    Harrison, Michael Roger
    Ramalingam, Sundhar
    Armstrong, Andrew J.
    George, Daniel J.
    Rini, Brian I.
    Zhang, Tian
    Ornstein, Moshe Chaim
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [23] Clinical outcomes according to ethnicity in patients with metastatic renal cell carcinoma (mRCC) treated with VEGF-targeted therapy (TT).
    Bosse, Dominick
    Xie, Wanling
    Wells, Connor
    Lalani, Aly-Khan A.
    Donskov, Frede
    Bent, Alisha
    Sim, Hao-Wen
    Beuselinck, Benoit
    Bamias, Aristotelis
    Porta, Camillo
    Vaishampayan, Ulka N.
    Pal, Sumanta K.
    Agarwal, Neeraj
    Srinivas, Sandy
    Rini, Brian I.
    Alva, Ajjai Shivaram
    Wood, Lori
    Kapoor, Anil
    Choueiri, Toni K.
    Heng, Daniel Yick Chin
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [24] Conditional survival (CS) for patients with metastatic renal cell carcinoma (mRCC) treated with vascular endothelial growth factor (VEGF)-targeted therapy (TT): Results from the International mRCC Database Consortium.
    Choueiri, Toni K.
    Xie, Wanling
    Harshman, Lauren Christine
    Bjarnason, Georg A.
    Knox, Jennifer J.
    MacKenzie, Mary J.
    Wood, Lori
    Vaishampayan, Ulka N.
    Tan, Min-Han
    Rha, Sun Young
    Donskov, Frede
    Agarwal, Neeraj
    Kollmannsberger, Christian K.
    North, Scott A.
    Rini, Brian I.
    Heng, Daniel Yick Chin
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [25] Patterns of care and outcomes of metastatic renal cell carcinoma (mRCC) patients (pts) with bone metastases (BM): A UK multicenter review
    Challapalli, A.
    Ratnayake, G.
    McGrane, J.
    Frazer, R.
    Gupta, S.
    Parslow, D. S.
    Kingdon, S. J.
    Lydon, A.
    Sharma, A.
    Tuthill, M.
    McCusker, C.
    Ford, V.
    Ferrera, A.
    Malik, J. M.
    Boh, Z.
    Jones, E.
    Geldart, T. R.
    Nelmes, S.
    Brown, J. E.
    Bahl, A.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1215 - S1215
  • [26] The impact of weight change during treatment with targeted therapy in patients with metastatic renal cell carcinoma (mRCC).
    Albiges, Laurence
    Mckay, Rana R.
    Lin, Xun
    de Velasco, Guillermo
    Simantov, Ronit
    Choueiri, Toni K.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [27] Third-line therapy in metastatic renal cell carcinoma (mRCC): Results from the International mRCC Database Consortium (IMDC)
    Heng, Daniel Yick Chin
    Stukalin, Igor
    Wells, Connor
    Donskov, Frede
    Rini, Brian I.
    Lee, Jae-Lyun
    Bjarnason, Georg A.
    Beuselinck, Benoit
    Smoragiewicz, Martin
    Alva, Ajjai Shivaram
    Srinivas, Sandy
    Wood, Lori
    Brugarolas, James
    Pal, Sumanta Kumar
    Yuasa, Takeshi
    Broom, Reuben James
    Kanesvaran, Ravindran
    Bamias, Aristotelis
    Knox, Jennifer J.
    Choueiri, Toni K.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [28] Metastatic renal cell carcinoma (mRCC) patients (pts) with sarcomatoid features treated with VEGF-targeted therapy
    Golshayan, A. R.
    George, S.
    Heng, D. Y.
    Elson, P.
    Wood, L.
    Garcia, J. A.
    Aydin, H.
    Zhou, M.
    Bukowski, R. M.
    Rini, B. I.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [29] Fourth-Line Therapy in Metastatic Renal Cell Carcinoma (mRCC): Results from the International mRCC Database Consortium (IMDC)
    Stukalin, Igor
    Wells, J. Connor
    Fraccon, Anna
    Pasini, Felice
    Porta, Camillo
    Lalani, Aly-Khan A.
    Srinivas, Sandy
    Bowman, I. Alex
    Brugarolas, James
    Lee, Jae-Lyun
    Donskov, Frede
    Beuselinck, Benoit
    Bamias, Aristotelis
    Rini, Brian, I
    Sim, Hao-Wen
    Agarwal, Neeraj
    Rha, Sun-Young
    Kanesvaran, Ravindran
    Choueiri, Toni K.
    Heng, Daniel Y. C.
    KIDNEY CANCER, 2018, 2 (01) : 31 - 36
  • [30] Angiotensin system inhibitors and survival in patients with metastatic renal cell carcinoma treated with VEGF-targeted therapy: A pooled secondary analysis of clinical trials
    Sorich, Michael J.
    Kichenadasse, Ganessan
    Rowland, Andrew
    Woodman, Richard J.
    Mangoni, Arduino A.
    INTERNATIONAL JOURNAL OF CANCER, 2016, 138 (09) : 2293 - 2299
12345